|
Oct 13
|
GLP-1 Stocks Aren't the Only Way to Benefit From the Weight Loss Drugs Boom
|
|
Oct 11
|
Next-gen weight loss drugs will have fewer side effects than Ozempic, pharma CEO says
|
|
Oct 9
|
FDA declines to approve Zealand Pharma’s hypoglycaemia therapy in infants
|
|
Jul 30
|
Better Weight Loss Drug Stock: Viking Therapeutics vs. Zealand Pharma
|
|
Jul 29
|
Zealand Pharma Appoints Eric Cox as Chief Commercial Officer
|
|
Jun 25
|
Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary shares raising gross proceeds of USD 1 billion / DKK 7 billion
|
|
Jun 25
|
Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900 million / DKK 6.257 billion to USD 1 billion / DKK 7 billion
|
|
Jun 25
|
Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 900 million / DKK 6.257 billion
|
|
Jun 24
|
Strength Seen in Zealand Pharma AS (ZLDPF): Can Its 11.6% Jump Turn into More Strength?
|
|
Jun 21
|
Existing home sales, a day with Fed's Susan Collins: Catalysts
|
|
Jun 21
|
Zealand Pharma's Weight Loss Drug Performs Well in Early Trials
|
|
Jun 21
|
Zealand Pharma surges on weight-loss drug trial results
|
|
Jun 21
|
Zealand Pharma says weight loss drug could be comparable to GLP1-RAs
|
|
Jun 21
|
Zealand Pharma soars after positive trial results from weight loss drug
|
|
Jun 20
|
Zealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose clinical trial with long-acting amylin analog petrelintide
|
|
Jan 12
|
Zealand Pharma completes registration of capital increase
|
|
Jan 10
|
Zealand Pharma major shareholder announcement: Avoro Capital Advisors LLC
|
|
Jan 2
|
Zealand Pharma to participate in the Goldman Sachs Healthcare C-Suite Unscripted Conference on January 4th
|
|
Dec 29
|
Total number of shares and voting rights in Zealand Pharma at December 29, 2023
|
|
Dec 23
|
UPDATE 2-Zealand says US FDA turns down drug for low blood sugar in infants
|